Press releases
Browse US-specific press releases here.
Please visit our Global website for access to global press releases dating back to 2009.
-
GSK demonstrates leadership in respiratory medicine at ATS 2017 with over 50 abstracts from across comprehensive portfolio
GSK will present 59 abstracts at the American Thoracic Society (ATS) conference 19-24 May, Washington DC, US.
-
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD
GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD.
-
Derek Hough Sends Social Media Stars, the Eh Bee Family, on Cross-Country Road Trip to Reimagine What’s Possible Despite Allergies
The Eh Bees will tackle allergy-triggering jobs to support local communities in seven cities.
-
GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older
GSK today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA).
-
Local nonprofits making Philly healthier can win $40,000
GlaxoSmithKline and The Philadelphia Foundation today issued the call for applications for the 2017 GSK IMPACT Awards.
-
Local nonprofits making the Triangle healthier can win $40,000
GlaxoSmithKline and Triangle Community Foundation today issued the call for applications for the 2017 GSK IMPACT Awards.
-
Science is a Slam Dunk with GSK Science in the Summer™
Classes return to local libraries again this summer with new Science of Sports course; online registration begins in May 2017
-
‘Get HYPE Philly!’ thrilled to win a Healthy10 Award
GSK IMPACT Grant winners recognized for building healthier schools and workforce for young people in Philadelphia.
-
GSK Consumer Healthcare Launches FLONASE® Sensimist™ Allergy Relief Nationwide
New OTC product with unique technology aims to help allergy sufferers find more complete relief.
-
GSK Announces Winners of 2016 Discovery Fast Track Boston Challenge
GSK has named two academic researchers winners of the 2016 Discovery Fast Track Boston Challenge.
-
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older (1)
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older (1)
-
GSK supports a healthy and happy Triangle with $400,000
GSK IMPACT Award winners build healthy communities by addressing care of elders, homelessness, education and other pressing issues
-
GSK celebrates 20 years of a healthy and happy Philadelphia
Ten nonprofits will receive $40,000 to support youth sports, safety, housing, and other pressing community health needs
-
GSK announces $200,000 grant to East Durham Children’s Initiative
Kids lead the way to develop healthier lifestyles
-
GSK unveils campaign to help prevent meningitis
Parents, young adults urged to educate themselves about meningitis B, responsible for one-third of U.S. cases
-
FDA Approves FLONASE® Sensimist™ Allergy Relief
FDA Approves FLONASE® Sensimist™ Allergy Relief.
-
GSK ships 2016-17 seasonal influenza vaccines for US market
- First-to-market with quadrivalent vaccine - Company to deliver up to 40 million doses
-
Update on GSK's response to the Zika virus disease outbreak
Since the outbreak of Zika virus disease began in the Americas late last year, GSK has been assessing how we can best help to respond.
-
GSK Uncovers The State of Uncontrolled Asthma in America
National survey of uncontrolled asthma patients finds majority mistakenly believe their asthma is under control
-
Free GSK Science in the Summer™ classes return to Philadelphia for the 30th year
When school is out, science is in! Online registration begins in May, space is limited.
